You are here

2013

Genomics Leading Innovation in BC

Monday, December 16, 2013

Seven new innovative research projects have been funded through Genome BC’s Strategic Opportunities Fund (SOF). The SOF program, with funding provided by Genome BC and several partners, aims to catalyze new projects and initiatives of strategic importance to BC’s economic sectors. These investments are increasingly recognized for providing foundational research and the projects provide an important basis for future research.

UCB Canada supports efforts to identify personalized treatment approach for drug-resistant epilepsy

Monday, December 9, 2013

Genome Canada and Génome Québec are pleased to announce UCB Canada Inc.’s contribution to a four-year study aimed at developing a personalized medicine approach to the early diagnosis of various types of epilepsy. The $10.8 million project, “Personalized medicine in the treatment of epilepsy”, forms the Canadian Epilepsy Network (CENet) and is led by Dr. Patrick Cossette at the University of Montreal Hospital Research Centre* (CRCHUM), as well as co-leaders, Dr.

COPD patients starting to breathe easier

Wednesday, December 4, 2013

Two BC researchers have combined forces to develop  a blood test that will identify patients at high risk for Chronic Obstructive Pulmonary Disease (COPD) lung attacks. This much needed test will help medical professionals provide better treatment and ultimately lead to patients with fewer attacks, and reduced hospitalization and emergency visits.
 

Call for proposals from The Office of the Privacy Commissioner of Canada

Wednesday, November 13, 2013

ANNOUNCEMENT – The Office of the Privacy Commissioner of Canada (OPC) has issued a call for proposals under its 2014-15 Contributions Program for project proposals aimed at promoting privacy and the protection of personal information in the private sector.

CHU de Québec Collaborates with PerkinElmer on a study funded by Genome Canada, Génome Québec, CIHR and Genome Alberta using DNA sequencing alone or in a contingent model with first trimester serum markers as non-invasive option to determine risk of Down

Monday, November 4, 2013

A team of clinical researchers led by CHU de Québec has received CAN$10.5 million from Génome Québec, Genome Canada, CIHR, Genome Alberta and other partners to recruit 5,600 pregnant women in Canada to study the potential of using DNA sequencing alone or in a contingent model with first trimester serum markers as a non-invasive method for detecting birth defects.

Call for proposals for the biobank of the Canadian Health Measures Survey

Friday, November 1, 2013

From November 1 to December 31, 2013, Statistics Canada is inviting researchers to apply for access to blood, urine and DNA samples from the Canadian Health Measures Survey (CHMS) for use in health studies. The biospecimens are available to any Canadian researcher that completes a review process and would benefit from a national population survey of about 5,600 participants per collection cycle.

Genome Canada welcomes five new Board members

Wednesday, October 30, 2013

Genome Canada is delighted to highlight the recent appointment of five new members to its Board of Directors. They include:

Fiona Brinkman, Professor, Molecular Biology and Biochemistry at Simon Fraser University

Jay Ingram, Broadcaster and Science Writer

Kim McConnell, Founder and former CEO, AdFarm

Moura Quayle, Professor, Strategic Design, Sauder School of Business, University of British Columbia

Donald Ziraldo, Co-founder, Inniskillin Wines

Dawn of a new era for children: Introducing Canada’s first integrated clinical genomic centre in pediatrics

Monday, October 21, 2013

Dr. Fabrice Brunet, Chief Executive Officer at Sainte-Justine UHC, and Marc LePage, President and CEO of Génome Québec, are extremely proud to announce the launch of Canada’s first integrated clinical genomic centre in pediatrics, an initiative currently at the forefront of global efforts in this area. "We are honoured to have the opportunity to make this partnership a reality in the presence of the Québec Premier, Pauline Marois, and Dr.

Pages